Cleavage of hemagglutinin-bearing lentiviral pseudotypes and their use in the study of influenza virus persistence

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Sawoo, Olivier ^a,b   Dublineau, Amélie ^a   Batéjat, Christophe ^a   Zhou, Paul ^c   Manuguerra, Jean Claude ^a   Leclercq, India ^a,b  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; PROTEIN HAT; PROTEIN TMPRSS2; PROTEINASE; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HIGH TEMPERATURE; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; LENTIVIRINAE; NONHUMAN; PANDEMIC INFLUENZA; PERSISTENT VIRUS INFECTION; PROTEIN CLEAVAGE; PROTEIN FUNCTION; SALINITY; SEASONAL VARIATION; STRAIN DIFFERENCE; SURVIVAL TIME; TEMPERATURE SENSITIVITY; VIRUS CHARACTERIZATION; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS STRAIN; VIRUS SURVIVAL; VIRUS TYPING; VIRUS VIABILITY; ANIMAL; CLASSIFICATION; DOG; GENETICS; HEAT; HEK293 CELL LINE; HUMAN; INFLUENZA A VIRUS; MDCK CELL LINE; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; DOGS; HEK293 CELLS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HOT TEMPERATURE; HUMANS; INFLUENZA A VIRUS; LENTIVIRUS; MADIN DARBY CANINE KIDNEY CELLS; SALINITY; STRESS, PHYSIOLOGICAL; WATER;

EID: 84923155630     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106192     Document Type: Article

References (40)

1. Nelson MI, Holmes EC (2007) The evolution of epidemic influenza. Nat Rev Genet 8: 196-205. doi:10.1038/nrg2053.
2. Kilbourne ED (2006) Influenza Pandemics of the 20th Century. Emerg Infect Dis 12: 9-14. doi:10.3201/eid1201.051254.
3. Scalera NM, Mossad SB (2009) The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus. Postgrad Med 121: 43-47. doi:10.3810/pgm.2009.09.2051.
4. Breban R, Drake JM, Stallknecht DE, Rohani P (2009) The role of environmental transmission in recurrent avian influenza epidemics. PLoS Comput Biol 5: e1000346. doi:10.1371/journal.pcbi.1000346.
5. Hinshaw VS, Webster RG, Turner B (1979) Water-bone transmission of influenza A viruses? Intervirology 11: 66-68.
6. Webster R g., Shortridge K f., Kawaoka Y (1997) Influenza: interspecies transmission and emergence of new pandemics. FEMS Immunol Med Microbiol 18: 275-279. doi:10.1111/j.1574-695X.1997.tb01056.x.
7. Tellier R (2009) Aerosol transmission of influenza A virus: a review of new studies. J R Soc Interface R Soc 6 Suppl 6: S783-790. doi:10.1098/rsif.2009. 0302.focus.
8. Weber TP, Stilianakis NI (2008) Inactivation of influenza A viruses in the environment and modes of transmission: a critical review. J Infect 57: 361-373. doi:10.1016/j.jinf.2008.08.013.
9. Gilbert M, Slingenbergh J, Xiao X (2008) Climate change and avian influenza. Rev Sci Tech Int Off Epizoot 27: 459-466.
10. Dublineau A, Batéjat C, Pinon A, Burguière AM, Leclercq I, et al. (2011) Persistence of the 2009 pandemic influenza A (H1N1) virus in water and on nonporous surface. PloS One 6: e28043. doi:10.1371/journal.pone.0028043.
11. Shigematsu S, Dublineau A, Sawoo O, Batéjat C, Matsuyama T, et al. (2013) Influenza A virus survival in water is influenced by the origin species of the host cell. Influenza Other Respir Viruses. doi:10.1111/irv.12179.
12. Rossman JS, Lamb RA (2011) Influenza virus assembly and budding. Virology 411: 229-236. doi:10.1016/j.virol.2010.12.003.
13. Bertram S, Glowacka I, Steffen I, Kühl A, Pöhlmann S (2010) Novel insights into proteolytic cleavage of influenza virus hemagglutinin. Rev Med Virol 20: 298-310. doi:10.1002/rmv.657.
14. Sun X, Whittaker GR (2013) Entry of influenza virus. Adv Exp Med Biol 790: 72-82. doi:10.1007/978-1-4614-7651-1-4.
15. Steinhauer DA (1999) Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258: 1-20. doi:10.1006/viro.1999.9716.
16. Zambon MC (2001) The pathogenesis of influenza in humans. Rev Med Virol 11: 227-241.
17. Garcia J-M, Lai JC (2011) Production of influenza pseudotyped lentiviral particles and their use in influenza research and diagnosis: an update. Expert Rev Anti Infect Ther 9: 443-455. doi:10.1586/eri.11.25.
18. Charneau P, Zennou V, Firat H (1998) Use of triplex structure dna sequences for transferring nucleotide sequences. Available: https://data.epo. org/publication-server/rest/v1.0/publication-dates/20120411/patents/ EP1071804NWB1/document.html. Accessed 24 February 2014.
19. Tsai C, Caillet C, Hu H, Zhou F, Ding H, et al. (2009) Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase. Vaccine 27: 6777-6790. doi:10.1016/j.vaccine.2009.08.056.
20. Lentivirus pseudotyped with influenza hemagglutinin and methods of use - Patent application (n.d.). Available: http://www.faqs.org/patents/app/ 20100137412. Accessed 2 December 2013.
21. Donald HB, Isaacs A (1954) Counts of Influenza Virus Particles. J Gen Microbiol 10: 457-464. doi:10.1099/00221287-10-3-457.
22. Olsen JC, Sechelski J (1995) Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA. Hum Gene Ther 6: 1195-1202. doi:10.1089/hum.1995.6.9-1195.
23. Böttcher-Friebertshäuser E, Freuer C, Sielaff F, Schmidt S, Eickmann M, et al. (2010) Cleavage of Influenza Virus Hemagglutinin by Airway Proteases TMPRSS2 and HAT Differs in Subcellular Localization and Susceptibility to Protease Inhibitors. J Virol 84: 5605-5614. doi:10.1128/JVI.00140-10.
24. Garoff H, Hewson R, Opstelten D-JE (1998) Virus Maturation by Budding. Microbiol Mol Biol Rev 62: 1171-1190. (Pubitemid 28558296)
25. Lodge R, Gottlinger H, Gabuzda D, Cohen EA, Lemay G (1994) The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J Virol 68: 4857-4861. (Pubitemid 24226550)
26. Escors D, Breckpot K (2010) Lentiviral vectors in gene therapy: their current status and future potential. Arch Immunol Ther Exp (Warsz) 58: 107-119. doi:10.1007/s00005-010-0063-4.
27. Alberini I, Del Tordello E, Fasolo A, Temperton NJ, Galli G, et al. (2009) Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses. Vaccine 27: 5998-6003. doi:10.1016/j.vaccine.2009.07.079.
28. Garcia J-M, Lagarde N, Ma ESK, de Jong MD, Peiris JSM (2010) Optimization and evaluation of an influenza A (H5) pseudotyped lentiviral particle-based serological assay. J Clin Virol 47: 29-33. doi:10.1016/j.jcv.2009.10.009.
29. Song G, Yang S, Zhang W, Cao Y, Wang P, et al. (2009) Discovery of the First Series of Small Molecule H5N1 Entry Inhibitors. J Med Chem 52: 7368-7371. doi:10.1021/jm900275m.
30. Zhang S, Xiao L, Zhou H, Yu Z, Chen H, et al. (2008) Generation and characterization of an H5N1 avian influenza virus hemagglutinin glycoprotein pseudotyped lentivirus. J Virol Methods 154: 99-103. doi:10.1016/j.jviromet. 2008.08.016.
31. Nefkens I, Garcia J-M, Ling CS, Lagarde N, Nicholls J, et al. (2007) Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis. J Clin Virol Off Publ Pan Am Soc Clin Virol 39: 27-33. doi:10.1016/j.jcv.2007.02.005. (Pubitemid 46575342)
32. Stanley WM (1944) The size of influenza virus. J Exp Med 79: 267-283.
33. Fredericksen BL, Wei BL, Yao J, Luo T, Garcia JV (2002) Inhibition of Endosomal/Lysosomal Degradation Increases the Infectivity of Human Immunodeficiency Virus. J Virol 76: 11440-11446. doi:10.1128/JVI.76.22.11440- 11446.2002. (Pubitemid 35231300)
34. Hasan MT, Subbaroyan R, Chang TY (1991) High-efficiency stable gene transfection using chloroquine-treated Chinese hamster ovary cells. Somat Cell Mol Genet 17: 513-517.
35. Wang W, Butler EN, Veguilla V, Vassell R, Thomas JT, et al. (2008) Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies. J Virol Methods 153: 111-119. doi:10.1016/j.jviromet.2008.07.015.
36. Schrauwen EJA, Bestebroer TM, Munster VJ, de Wit E, Herfst S, et al. (2011) Insertion of a multibasic cleavage site in the haemagglutinin of human influenza H3N2 virus does not increase pathogenicity in ferrets. J Gen Virol 92: 1410-1415. doi:10.1099/vir.0.030379-0.
37. Scott S, Molesti E, Temperton N, Ferrara F, Bottcher-Friebertshauser E, et al. (2012) The use of equine influenza pseudotypes for serological screening. J Mol Genet Med Int J Biomed Res 6: 304-308.
38. Domanska-Blicharz K, Minta Z, Smietanka K, Marché S, van den Berg T (2010) H5N1 high pathogenicity avian influenza virus survival in different types of water. Avian Dis 54: 734-737.
39. Brown JD, Goekjian G, Poulson R, Valeika S, Stallknecht DE (2009) Avian influenza virus in water: infectivity is dependent on pH, salinity and temperature. Vet Microbiol 136: 20-26. doi:10.1016/j.vetmic.2008.10.027.
40. Rachakonda PS, Veit M, Korte T, Ludwig K, Böttcher C, et al. (2007) The relevance of salt bridges for the stability of the influenza virus hemagglutinin. FASEB J Off Publ Fed Am Soc Exp Biol 21: 995-1002. doi:10.1096/fj.06-7052hyp. (Pubitemid 46495718)